Qualigen Therapeutics (QLGN) Financials

$2.33

$0.01 (0.30%)

As on 20-Jan-2026 09:30EDT

Market cap

$7 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

1.1

P/B Ratio

4.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	2.24	--	5.20	4.98	5.65	4.31
Cost of Revenue	0.02	--	5.21	4.30	4.33	7.19
Gross Profit	1.10	--	0.00	0.68	1.32	-2.88
Operating Expenses	5.42	5.76	6.10	18.62	23.98	9.80
Operating Profit (EBIT)	-5.42	-5.76	-11.30	-17.94	-22.66	-12.68
Other Income	--	--	--	--	--	--
Profit before Tax	-5.42	-6.15	-12.48	-21.30	-17.89	-20.42
Provision for Tax	0.01	0.01	0.00	-0.27	0.01	0.00
Profit after Tax (Net Income)	-5.43	-6.16	-13.42	-21.03	-17.90	-20.42
Minority Interest	--	--	0.34	2.39	--	--
Consolidated Profit	--	--	--	-18.64	-17.90	-26.06

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	38.55	2.68	-2.10	7.24	16.56	18.29
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	1.71	1.64	0.40
Current Liabilities	4.92	2.01	4.14	8.61	4.64	10.43
Total Liabilities	48.39	4.69	2.03	19.08	22.84	29.13

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.00	0.00	0.87	8.26	2.04	0.90
Current Assets	43.47	4.68	1.17	10.82	20.80	28.22
Total Assets	48.39	4.69	2.03	19.08	22.84	29.13
Total Debt*	3.24	--	1.30	1.76	1.68	0.63
Net Current Assets	38.55	2.68	-2.97	2.21	16.16	--

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-6.33	-10.30	-13.25	-14.73	-9.76
Cash Flow from Investing Activities	--	-1.91	4.22	-0.18	-0.14	-0.16
Cash from Financing Activities	--	9.01	-0.55	2.91	8.43	33.76
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-3.56	-8.36	-2.57	-5.00	-5.72	-8.65
Cash EPS ($)	--	-8.36	-2.57	-4.91	-5.61	-8.54
Adjusted Book Value ($)	--	3.64	--	1.72	5.29	7.75
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-8.59	-1.97	-3.15	-4.71	-4.13
Free Cash Flow per Share ($)	--	-8.59	-1.97	-3.22	-4.75	-4.22

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-657.09	-327.71	-154.47	-96.31	-202.92
ROE (%)	-26.37	-2,140.54	-522.87	-176.76	-102.68	-210.56
ROA (%)	-19.71	-183.32	-127.08	-100.36	-68.88	-127.92
EBIT Margin (%)	-178.33	--	-217.20	-277.98	-400.85	-262.49
Net Margin (%)	-242.92	--	-257.79	-422.08	-316.55	-474.16
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	-1.00	0.04	-0.12	0.31	-0.23
EBIT Growth (%)	41.22	49.03	18.40	38.87	-100.50	-653.36
Net Profit Growth (%)	30.95	54.09	36.21	-17.53	12.35	-1,042.31
EPS Growth (%)	-151.28	-2.26	0.49	0.13	0.34	-1.71
Book Value Growth (%)	4,943.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	1.13	-0.50	-0.21	-0.26	-0.19	-0.35
Price / Book Value	4.91	1.16	-1.37	0.75	0.20	0.39
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.05	-0.37	-0.33	-0.29	0.56	1.45
Close Price ($)	5.72	4.21	27.50	64.45	535.00	1,505.00
High Price ($)	10.45	29.44	96.50	760.00	2,217.00	10,748.75
Low Price ($)	1.61	3.34	27.01	55.50	440.00	1,435.00
Market Cap ($ Cr)	6.53	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	--	-0.62	0.24	0.10	0.03
Short term debt to equity ratio	0.08	--	-0.62	0.06	0.01	0.02
Current Ratio	8.83	2.33	0.28	1.26	4.49	2.71
Quick Ratio	8.83	--	--	1.07	4.26	2.61
Interest Coverage	-6.11	-6.34	-7.41	-402.75	-530.84	-54.95

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	194.34	--	--	10.81	14.55	14.30
Asset Turnover	0.08	--	0.49	0.24	0.22	0.27
Receivable days	--	--	37.80	49.87	46.45	26.15
Inventory Days	--	--	111.22	112.14	84.70	41.01
Payable days	--	--	99.65	63.91	58.47	48.75
Cash Conversion Cycle	--	--	49.37	98.10	72.69	18.41

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.